4//SEC Filing
Finizio Robert G 4
Accession 0001387131-21-007122
CIK 0000025743other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:54 PM ET
Size
8.8 KB
Accession
0001387131-21-007122
Insider Transaction Report
Form 4
Finizio Robert G
DirectorChief Executive Officer10% Owner
Transactions
- Award
Restricted Stock Units
2021-07-01+746,667→ 746,667 totalExercise: $0.00→ Common Stock (746,667 underlying) - Award
Performance Stock Units
2021-07-01+1,493,333→ 1,493,333 totalExercise: $0.00→ Common Stock (1,493,333 underlying)
Footnotes (2)
- [F1]One half of the performance stock units (PSUs) vest based on the issuer achieving certain revenue milestones over the period from 2021 through 2023, and one half of the PSUs vest based on the issuer achieving certain earnings before interest, taxes, depreciation and amortization (EBITDA) milestones no later than December 31, 2023. In the event that any of the foregoing are not achieved, the corresponding portion of the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on the milestones achieved. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.
- [F2]Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning July 1, 2022, becoming fully vested on July 1, 2024.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001532235
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 5:54 PM ET
- Size
- 8.8 KB